
James Martinell
Examiner (ID: 304, Phone: (571)272-0719 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1207, 1631, 1634, 1633, 1302, 1803, 1804, 1805, 1802 |
| Total Applications | 2308 |
| Issued Applications | 1281 |
| Pending Applications | 221 |
| Abandoned Applications | 809 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17627597
[patent_doc_number] => 20220162612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => SYNTHETIC TRANSFER RNA WITH EXTENDED ANTICODON LOOP
[patent_app_type] => utility
[patent_app_number] => 17/602251
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602251 | SYNTHETIC TRANSFER RNA WITH EXTENDED ANTICODON LOOP | Apr 8, 2020 | Pending |
Array
(
[id] => 17287233
[patent_doc_number] => 11203774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Protecting group chemistry for clean, reductant-free dyeing
[patent_app_type] => utility
[patent_app_number] => 16/842401
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 22043
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842401 | Protecting group chemistry for clean, reductant-free dyeing | Apr 6, 2020 | Issued |
Array
(
[id] => 19977307
[patent_doc_number] => 12344769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-01
[patent_title] => Method for extracting gelatin
[patent_app_type] => utility
[patent_app_number] => 17/439859
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1023
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439859 | Method for extracting gelatin | Apr 6, 2020 | Issued |
Array
(
[id] => 17642293
[patent_doc_number] => 20220170031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => EUKARYOTIC HOST SYSTEM FOR PRODUCING RECOMBINANT PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/600553
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600553 | EUKARYOTIC HOST SYSTEM FOR PRODUCING RECOMBINANT PROTEINS | Mar 30, 2020 | Pending |
Array
(
[id] => 18718151
[patent_doc_number] => 11795486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Enzymatic method for preparation of GDP-fucose
[patent_app_type] => utility
[patent_app_number] => 17/593929
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 32711
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17593929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/593929 | Enzymatic method for preparation of GDP-fucose | Mar 30, 2020 | Issued |
Array
(
[id] => 18125265
[patent_doc_number] => 20230010880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => ENGINEERED POLYPEPTIDES AND ITS APPLICATION IN THE SYNTHESIS OF TYROSINE OR TYROSINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/440954
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440954
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440954 | Engineered polypeptides and its application in the synthesis of tyrosine or tyrosine derivatives | Mar 29, 2020 | Issued |
Array
(
[id] => 20239598
[patent_doc_number] => 12419902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Anti-viral and anti-tumoral compounds
[patent_app_type] => utility
[patent_app_number] => 17/442198
[patent_app_country] => US
[patent_app_date] => 2020-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 47
[patent_no_of_words] => 44944
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442198 | Anti-viral and anti-tumoral compounds | Mar 28, 2020 | Issued |
Array
(
[id] => 17830490
[patent_doc_number] => 20220267794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOSITIONS, DEVICES, AND METHODS FOR TREATING FABRY DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/598176
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598176 | COMPOSITIONS, DEVICES, AND METHODS FOR TREATING FABRY DISEASE | Mar 26, 2020 | Pending |
Array
(
[id] => 17673088
[patent_doc_number] => 20220186255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS FOR THE MANUFACTURE OF RECOMBINANT VIRAL VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/598503
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598503 | Methods for the manufacture of recombinant viral vectors | Mar 25, 2020 | Issued |
Array
(
[id] => 16236866
[patent_doc_number] => 20200254100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => ANIONIC-CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/829843
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/829843 | ANIONIC-CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USING THE SAME | Mar 24, 2020 | Abandoned |
Array
(
[id] => 16437400
[patent_doc_number] => 20200354726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHOD OF MASS-PRODUCING CARBONIC ANHYDRASE IN PLANT
[patent_app_type] => utility
[patent_app_number] => 16/825022
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825022 | METHOD OF MASS-PRODUCING CARBONIC ANHYDRASE IN PLANT | Mar 19, 2020 | Abandoned |
Array
(
[id] => 18226790
[patent_doc_number] => 20230065784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOSITION AND METHOD FOR REDUCING EXPRESSION OF CHECKPOINT INHIBITORS IN T CELLS EXPRESSING A CAR OR CTL
[patent_app_type] => utility
[patent_app_number] => 17/440832
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5765
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440832
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440832 | COMPOSITION AND METHOD FOR REDUCING EXPRESSION OF CHECKPOINT INHIBITORS IN T CELLS EXPRESSING A CAR OR CTL | Mar 19, 2020 | Abandoned |
Array
(
[id] => 17520724
[patent_doc_number] => 20220106573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => ALTERNATE DETERGENTS FOR VIRAL INACTIVATION
[patent_app_type] => utility
[patent_app_number] => 17/432156
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432156 | ALTERNATE DETERGENTS FOR VIRAL INACTIVATION | Mar 17, 2020 | Pending |
Array
(
[id] => 16437371
[patent_doc_number] => 20200354697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY
[patent_app_type] => utility
[patent_app_number] => 16/821018
[patent_app_country] => US
[patent_app_date] => 2020-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16821018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/821018 | Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy | Mar 16, 2020 | Issued |
Array
(
[id] => 16361391
[patent_doc_number] => 20200318142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => ALGAL BIOFUEL PRODUCTION AS AN AIR SEPARATION UNIT FOR SYNGAS, HYDROGEN, OR POWER PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/820287
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820287 | ALGAL BIOFUEL PRODUCTION AS AN AIR SEPARATION UNIT FOR SYNGAS, HYDROGEN, OR POWER PRODUCTION | Mar 15, 2020 | Abandoned |
Array
(
[id] => 17490667
[patent_doc_number] => 11279959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Methods and enzyme catalysts for the synthesis of non-canonical amino acids
[patent_app_type] => utility
[patent_app_number] => 16/820538
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 26
[patent_no_of_words] => 24023
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820538
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820538 | Methods and enzyme catalysts for the synthesis of non-canonical amino acids | Mar 15, 2020 | Issued |
Array
(
[id] => 17642236
[patent_doc_number] => 20220169974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => NEW LACTIC ACID BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/437255
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437255 | Lactic acid bacteria | Mar 12, 2020 | Issued |
Array
(
[id] => 16112329
[patent_doc_number] => 20200208187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => ENZYMATIC PRODUCTION OF D-ALLULOSE
[patent_app_type] => utility
[patent_app_number] => 16/818107
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818107 | Enzymatic production of D-allulose | Mar 12, 2020 | Issued |
Array
(
[id] => 16111553
[patent_doc_number] => 20200207799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => GLYCOLIPOPEPTIDE BIOSURFACTANTS
[patent_app_type] => utility
[patent_app_number] => 16/817193
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16817193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/817193 | Glycolipopeptide biosurfactants | Mar 11, 2020 | Issued |
Array
(
[id] => 20548977
[patent_doc_number] => 12559759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-24
[patent_title] => Fusion polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/437189
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 11793
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437189 | Fusion polypeptides | Mar 8, 2020 | Issued |